ENDOCRINE NEUROMYOPATHIES - 11/09/11
Doi : 10.1016/S0733-8619(05)70339-X
Angela Anagnos, MD a, c, d, Robert L. Ruff, MD, PhD a, b, d, Henry J. Kaminski, MD a, c, d
a Departments of Neurology (AA, RLR, HJK)
b Neurosciences (RLR), Case Western Reserve University School of Medicine
c Department of Neurology (AA, HJK), University Hospitals of Cleveland
d Department of Neurology (AA, RLR, HJD), Department of veterans Medical Center in Cleveland, Cleveland, Ohio
Plan
| Address reprint request to Henry J. Kaminski, MD, Department of Neurology, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106 This work was supported by the Office of Research and Development, Medical Research Service of the Department of Veterans Affairs. Dr. Kaminski is supported by National Institutes of Health grant (EY-0032). Dr. Ruff received support from the Muscular Dystrophy Association. |
© 1997
W. B. Saunders Company. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 15 - N° 3
P. 673-696 - août 1997 Retour au numéro
Article précédent
- MYOGLOBINURIA, MALIGNANT HYPERTHERMIA, NEUROLEPTIC MALIGNANT SYNDROME AND SEROTONIN SYNDROME
- Tulio E. Bertorini
- MUSCLE PAIN, FATIGUE, AND FASICULATIONS
- John C. Kincaid
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?